SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002416
Filing Date
2023-11-13
Accepted
2023-11-13 16:53:59
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20230930x10q.htm   iXBRL 10-Q 1556629
2 EX-10.1 eyen-20230930xex10d1.htm EX-10.1 533956
3 EX-31.1 eyen-20230930xex31d1.htm EX-31.1 13908
4 EX-31.2 eyen-20230930xex31d2.htm EX-31.2 13782
5 EX-32.1 eyen-20230930xex32d1.htm EX-32.1 5936
6 EX-32.2 eyen-20230930xex32d2.htm EX-32.2 6915
  Complete submission text file 0001410578-23-002416.txt   7978556

Data Files

Seq Description Document Type Size
7 EX-101.SCH eyen-20230930.xsd EX-101.SCH 62721
8 EX-101.CAL eyen-20230930_cal.xml EX-101.CAL 55629
9 EX-101.DEF eyen-20230930_def.xml EX-101.DEF 176150
10 EX-101.LAB eyen-20230930_lab.xml EX-101.LAB 442072
11 EX-101.PRE eyen-20230930_pre.xml EX-101.PRE 353185
64 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20230930x10q_htm.xml XML 1358081
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 231399744
SIC: 2834 Pharmaceutical Preparations